baber/WOPTO huggingface dataset:
Patent FI-894405-A0 (FI)
Inventor: KELLER WERNER
IPC: B22D41/08
Filed: 1989-09-18
Abstract: The refractory stator/rotor unit for a nozzle gate of a vessel (11) containing molten metal consists of a stator (15) fastened in the vessel wall (14), and of a rotor (16), which is rotatable in the latter from the underside (11') of the base of the vessel and serves for opening or closing the gate. The unit projecting into the vessel has transverse openings (17, 18) extending therein and, starting from these openings (17, 18), a nozzle opening (19) leading out of the vessel. In the entire region lying within the vessel, a sealing cylindrical surface (20), surrounding the transverse openings (17, 18) is provided between the rotor (16) and the rotator (15) while in the region lying in the vessel wall (14) a clearance (22), compensating for the different thermal expansions of stator and rotor, is provided in order to prevent the unit from seizing. A gate system is thus provided which is very simple and space-saving and functions with high operational reliability. 
<IMAGE>
Patent FI-903464-A0 (FI)
Inventor: ELTING JAMES
IPC: G01N33/68
Filed: 1990-07-09
Abstract: A method for conferring or increasing the antigenicity of a disulfide-crosslinked protein by treating the protein with an oxidizing agent, such as periodate, having an oxidation potential sufficient to cleave disulfide linkages. Excess oxidizing agent is then inactivated by addition of a reducing agent. The resulting protein exhibits an increase in its ability to be bound by select antibodies, particularly monoclonal antibodies directed to linear peptide epitopes in the protein.
Patent FI-903515-A0 (FI)
Inventor: OLSEN EGIL
IPC: G01N33/546
Filed: 1990-07-11
Abstract: A method for the qualitative or quantitative determination of an analyte in a test sample wherein a labelled reagent is caused to be immobilized in bound form on a solid phase to provide an indication of the presence or quantity of the analyte in the sample is disclosed and is characterized in that the labelled reagent comprises a gold sol bound to a substance capable of specifically binding to said analyte or to a specific binding partner therefor, at least 75% by weight of the gold particles of the gold sol having a mean diameter of less than 5 nanometers.
Patent FI-905797-A0 (FI)
Inventor: KARPPINEN KIRSTI MARJATTA
IPC: C03C13/06
Filed: 1990-11-23
Abstract: A mineral fiber composition which is soluble in biological fluids contains substantially45-65% by weight of SiO215-40% by weight of CaO0-20% by weight of MgO0-6% by weight of Na2O+K2Oand in addition aluminium and/or iron oxides as well as phosphorus oxide in such amounts that the weight ratio of P2O5 to the sum of Al2O3 and iron oxide is circa 0.4 to 6.
Patent FI-913624-A0 (FI)
Inventor: JONES MALCOLM GLYN
IPC: A23L9/20
Filed: 1991-07-30
Abstract: The invention concerns with whippable non-dairy creams with fat levels of 15-60 wt%, wherein the fat consists for 25-85 wt% of a liquid oil and for the rest of a hard fat that possess excellent properties, like a whipping time less than 6 min. Also a production-process is described, which includes a tempering step to make the NDC whippable within 4 min.
Patent FI-921791-A0 (FI)
Inventor: EDWARDS DAVID BRIAN
IPC: B65D25/14
Filed: 1992-04-22
Abstract: PCT No. PCT/GB90/01628 Sec. 371 Date Sep. 22, 1993 Sec. 102(e) Date Sep. 22, 1993 PCT Filed Oct. 23, 1990 PCT Pub. No. WO91/05715 PCT Pub. Date May 2, 1991.A container suitable for hazardous liquids such as agrochemical concentrates comprises an outer shell (I) made from a compressed fiber material, typically recycled biodegradable material, having an associated barrier (3) comprising a water soluble or water dispersible polymeric material. The container is stackable. A method of making the container, and of testing the coating for leaks, is also described.
Patent FI-925962-A0 (FI)
Inventor: MEINANDER PAUL OLOF
IPC: D21F1/20
Filed: 1992-12-31
Abstract: PCT No. PCT/F191/00177 Sec. 371 Date Jan. 5, 1993 Sec. 102(e) Date Jan. 5, 1993 PCT Filed Jul. 5, 1990 PCT Pub. No. WO92/01110 PCT Pub. Date Jan. 23, 1992.A turbulence roll for a web former. The roll generates high frequency small-scale vibration in the stock on the forming fabric whereby fluidization of the partially formed fiber mat and dispersion of fiber flocs in the stock is brought about. The turbulence roll is formed of a shaft on which a plurality of discs (32) is disposed a distance apart from each other and a plurality of lengthwise extending rods (34) is attached to the rims of the discs and spaced apart from each other.
Patent FI-933696-A0 (FI)
Inventor: MATIERE MARCEL
IPC: F16L1/038
Filed: 1993-08-23
Abstract: The invention relates to an elongated housing (1) intended to withstand an internal pressure which may exceed 10 bars and forming a tubular sealed space (A) having a truncated cross-section, comprising a lower portion formed of a rigid concrete slab (2) resting on the ground and an upper portion (3) consisting of a thin metal wall shaped like a curved vault extending between two side extremities (31, 31') parallel to the longitudinal axis and each connected to the slab (2) by means of a longitudinal connection part connected tangentially to the side extremity (31, 31') of the vault (3). According to the invention, the upper face (22) of the slab (2) has a width substantially equal to the spacing between the two side extremities (31, 31') of the curved vault (3) and each connection part is comprised of a flat plate (4, 4') which extends in the prolongation of the vault (3) and is applied from the outside against the corresponding side face (23, 23') of the slab (2), each plate (4,4') being associated with support means (5, 42) capable of opposing the slipping of said plate (4, 4') along the corresponding side face (23, 23') of the slab (2) caused by forces (15) due to internal pressure and to the separation of said plates (4, 4') as a result of external forces (13).
Patent FI-935424-A0 (FI)
Inventor: KLICEK MICHAEL S
IPC: A61B18/12
Filed: 1993-12-03
Abstract: An electrical circuit system which provides electrical energy to a surgical apparatus having ultrasonic fragmentation, aspiration and electrosurgical coagulation capabilities, which system also includes an impedance sensing network and automatic feedback power output control to reduce RF power output as load impedance increases, thereby reducing RF leakage current.
Patent FI-942572-A0 (FI)
Inventor: ANDERSSON ROINE
IPC: B04C5/081
Filed: 1994-06-01
Abstract: PCT No. PCT/SE92/00814 Sec. 371 Date Jun. 1, 1994 Sec. 102(e) Date Jun. 1, 1994 PCT Filed Nov. 26, 1992 PCT Pub. No. WO93/10908 PCT Pub. Date Jun. 10, 1993.In a hydrocyclone the separation chamber (2) has a circumferential wall (3) provided with at least one turbulence creating member (12), which extends along the circumferential wall and crosses a helical path (10) along which a liquid stream is generated during operation. According to the invention, the turbulence creating member is formed by an offset (12) on the circumferential wall (3). The offset is formed and dimensioned such that said liquid stream substantially loses its contact with the circumferential wall as the liquid stream passes the offset. As a result turbulence is created in a layer of the liquid stream situated closest to the circumferential wall, without the liquid stream developing any substantial flow component directed inward in the separation chamber.
Patent FI-955419-A0 (FI)
Inventor: CELESTE ANTHONY J
IPC: A61P43/00
Filed: 1995-11-10
Abstract: Purified BMP-11 proteins and processes for producing them are disclosed. Recombinant DNA molecules encoding the BMP-11 proteins arc also disclosed. The proteins may be useful in regulating follicle stimulating hormone, such as for contraception. In addition, the proteins may be useful for the induction of bone, cartilage and/or other connective tissue.
Patent FI-970147-A0 (FI)
Inventor: HELLENDAHL BEATE
IPC: C07D403/12
Filed: 1997-01-14
Abstract: PCT No. PCT/EP95/02781 Sec. 371 Date Jan. 14, 1997 Sec. 102(e) Date Jan. 14, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/02520 PCT Pub. Date Feb. 1, 1996The present invention relates to triazole compounds of the following formula: where R1, R2, A, B and Ar have the meanings stated in the description. The compounds according to the invention have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.
Patent IL-60710-A0 (IL)
Title: 5-imino-imidazolidin-2-ones and their use as herbicides
IPC: A01N43/50
Filed: 1980-07-30
Abstract: 1. Claims for the contracting states BE, CH, LI, DE, FR, GB, IT, NL, SE A 5-imino-imidazolin-2-one of the general formula  see diagramm : EP0024570,P23,F1  where R**1 , R**2 and R**3 are identical or different and, independently of one another, denote hydrogen, halogen, unsubstituted or halogen-substituted alkyl, alkoxy or alkylthio, each of from 1 to 4 carbon atoms, cyano or nitro. 1. Claims for Austria A herbicide containing a 5-imino-imidazolidin-2-one of the general formula  see diagramm : EP0024570,P24,F2  where R**1 , R**2 and R**3 are identical or different and, independently of one another, denote hydrogen, halogen, unsubstituted or halogen-substituted alkyl, alkoxy or alkylthio, each of from 1 to 4 carbon atoms, cyano or nitro.
Patent IL-62946-A0 (IL)
Title: Process for the preparation of hydantoin derivatives and novel intermediate in said process
IPC: C07D233/80
Filed: 1981-05-25
Abstract: 1. Process for the manufacture of N-substituted 1-carbamoyl-3-(3,5-dichlorophenyl)-hydantoins of the formula: <IMAGE>  (I)  in which R1=alkyl (C1-C4) or phenyl and R2=H or alkyl (C1-C4). 2. This process comprises two steps: a. reacting phosgene with 3-(3,5-dichlorophenyl)-hydantoin in an inert organic solvent medium, in the presence of an acid acceptor, in order to form 1-chlorocarbonyl-3-(3,5-dichlorophenyl)-hydantoin, and b. reacting the chlorocarbonyl formed with an amine HNR1R2 in an inert organic solvent, in the presence of an acid acceptor. 3. This process makes it possible to obtain the products I, which can be used as agricultural fungicides, with good yields.
Patent IL-78493-A0 (IL)
Title: Plastic stopper for container
IPC: B65D47/08
Filed: 1986-04-15
Abstract: A stopper incorporates a base (1) with a pouring opening (15) and a one-piece cap (2) divided into two sections. The cap (2) is connected to the base (1) through a flexible-strip hinge (3). The part (20) of the cap (2) closer to the flexible-strip hinge (3) and the part (21) further from the hinge are connected to each other through a snap hinge (4). There is at least one opening (17) in the base (1) in which a matching catch (26) on the part (20) engages, whereas the part can still be opened and closed freely through the snap hinge (4).
Patent IL-84312-A0 (IL)
Title: Ifosfamide lyophilisate and its preparation
IPC: A61K47/10
Filed: 1987-10-29
Abstract: 1. A lyophilized preparation consisting of ifosfamide and 0.1 to 17 parts by weight hexitol per part by weight ifosfamide and, optionally, other standard pharmaceutical auxiliaries.
Patent IL-90925-A0 (IL)
Title: Lactonization of mevinic acids and analogs thereof
IPC: A61K31/35
Filed: 1989-07-11
Abstract: A process for the lactonization of mevinic acid HMG-CoA reductase inhibitors and analogs thereof is disclosed.
Patent IL-93033-A0 (IL)
Title: Polyhaloaromatic ester flame retardants for polyolefin resins
IPC: C08K5/06
Filed: 1990-01-11
Abstract: Flame retardant compositions are provided containing at least one ester of a polyhaloaromatic acid and at least one polyolefin resin. The compositions may also contain one or more brominated and/or chlorinated compounds to provide additional flame retardancy, and other resins or engineering thermoplastics may be blended with the polyolefin. In addition to providing flame retardancy, the polyhaloaromatic acid esters are effective as processing and compatibilizing aids for the resin, and may also function as tackifiers, mold release agents, plastisols, adhesives, plasticizers, polymer additives, and aids in preventing melt fracture.
Patent IL-97516-A0 (IL)
Title: Light stable physical developer containing a substituted quinolinium methyl sulfonate
IPC: G03C1/72
Filed: 1991-03-12
Abstract: A light-stable physical developer comprising a solution of silver ions, a desensitizing agent and a reducing agent. A method for the detection of one or more components of an aggregate formed between at least one specific binding agent and its corresponding bindable substance by labelling at least one component of said aggregate with a marker and contacting said aggregate with said light-stable physical developer, whereby under influence of the marker a metal particle is formed which can be detected. Further the invention also relates to products, e.g. a test-kit adapted for carrying out the above mentioned method.
Patent FI-20021205-A0 (FI)
Inventor: LEHIKOINEN JUHANI
IPC: F24B1/24
Filed: 2002-06-20
Abstract: A heating stove type fireplace, comprised of a metal outer shell (1,2); a furnace (4) with an openable hatch and a grate (3); a heat storage unit (5) located in the area of the essentially hottest burn gas flow; a smoke gases afterglow heat transfer unit (6) to effect direct heat transfer from smoke gases coming from the heat storage unit into the surrounding airspace (7); as well as a chimney connection (8) for smoke gases.
Patent FI-20080120-A0 (FI)
Inventor: AURANEN ILPO
IPC: G01N/
Filed: 2008-02-15
Abstract: A method for forming an ore sample (2) and an ore sample (2), the ore sample in said method being prepared of drill cuttings, whereby drill cuttings are collected for preparing the sample (2) into a sample vessel layer by layer according to the advance of the drilling process where the drill cuttings are generated.
Patent IL-104696-A0 (IL)
Title: Dual carrier immunogenic construct and a vaccine containing the same
IPC: A61K39/385
Filed: 1993-02-11
Abstract: A dual carrier immunogenic construct comprised of at least one primary carrier comprising a large molecular weight molecule of greater than 70 kD molecular weight and at least one secondary carrier comprising a T-dependent antigen conjugated to a primary carrier. The dual carrier immunogenic construct may further comprise moieties such as haptens and antigens. Such immunogenic constructs are suitable for use in the diagnosis, treatment, and prevention of diseases.
Patent IL-104930-A0 (IL)
Title: Components for smoking articles and their manufacture
IPC: A24D1/22
Filed: 1993-03-03
Abstract: Disclosed are new fuel components for smoking articles such as cigarettes, new methods of making such fuel components, and cigarettes or other smoking articles incorporating the new fuel components. Fuel components for smoking articles are formed by continuously extruding a composition to form a preselected shape, circumscribing the continuously extruded composition with a layer of material to form a wrapped rod or composite member, preferably bonding the fuel element to the layer of material, and cutting the resulting composite member into predetermined lengths for use in assembling smoking articles. <IMAGE>
Patent IL-125695-A0 (IL)
Title: A protective undergarment
IPC: A41C3/00
Filed: 1998-08-07
Abstract: A protective undergarment including an integrally formed undergarment body formed of a liquid impermeable material, and an absorptive pad associated with the integrally formed undergarment body.
Patent IL-129306-A0 (IL)
Title: Method and apparatus for providing high speed data communications in a cellular environment
IPC: H04W28/22
Filed: 1997-10-27
Abstract: A method and apparatus for transmitting digital data in a cellular environment. Adjacent cells of the cellular system are prevented from simultaneously transmitting data. Because the noise from transmissions of adjacent cells is a primary source of interference, the transmission rate of power limited base stations can be dramatically increased when the noise from adjacent cells is eliminated. The transmissions to each subscriber station are made at a fixed transmission power level. However, the data rate of transmitted signals differs from one subscriber station to another depending the path loss differences. In a first exemplary embodiment, the data rate of transmissions to a subscriber station is determined by selecting an encoding rate for the transmitted signal while holding the symbol rate constant. In a second exemplary embodiment, the data rate of transmissions to a subscriber station is determined by selection a modulation format for the transmitted signal which directly changes the symbol rate of transmission to a subscriber station.
Patent IL-130362-A0 (IL)
Title: Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
IPC: A61P35/00
Filed: 1998-03-03
Abstract: This invention concerns compounds of formulathe pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein the dotted line represents an optional bond; X is oxygen or sulfur; -A- is a bivalent radical of formula; R1 and R2 each independently are hydrogen, hydroxy, halo, cyano, C1-6alkyl, trihalomethyl, trihalomethoxy, C2-6alkenyl, C1-6alkyloxy, hydroxyC1-6alkyloxy, C1-6alkyloxyC1-6alkyloxy, C1-6alkyloxycarbonyl, aminoC1-6alkyloxy, mono- or di(C1-6alkyl)aminoC1-6alkyloxy, Ar, Ar-C1-6alkyl, Ar-oxy, Ar-C1-6alkyloxy; or when on adjacent positions R1 and R2 taken together may form a bivalent radical; R3 and R4 each independently are hydrogen, halo, cyano, C1-6alkyl, C1-6alkyloxy, Ar-oxy, C1-6alkylthio, di(C1-6alkyl)amino, trihalomethyl, trihalomethoxy, or when on adjacent positions R3 and R4 taken together may form a bivalent radical; R5 is an imidazolyl substituted with hydrogen or C1-6alkyl; R6 hydrogen, hydroxy, halo, cyano, optionally substituted C1-6alkyl, C1-6alkyloxycarbonyl or Ar; or a radical of formula -O-R7, -S-R8, -N-R8R9; and Ar is optionally substituted phenyl; having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.
Patent IL-145643-A0 (IL)
Title: C7 carbamoyloxy substituted taxanes as antitumor agents
IPC: A61K31/443
Filed: 2001-02-02
Abstract: Taxanes having a carbamoyloxy substituent at C(7), a hydroxy substituent at C(10, and a range of C(2), C(9), C(14), and side chain substituents.
Patent IL-148634-A0 (IL)
Title: Neutron brachytherapy device and method
IPC: G21G4/08
Filed: 2000-09-13
Abstract: A neutron source for neutron brachytherapy is disclosed that may generate neutrons to treat cancer and other tumors. The neutron source in accordance with the invention may include a capsule into which the neutron emitting material is loaded and a guide wire. A coiled wire may be placed around the capsule and the guide wire to strengthen the capsule and guide wire. In accordance with one embodiment, the capsule containing the neutron emitting material is sufficiently thin so that the helium gas generated during the decay of the neutron emitting material may escape into the atmosphere. In a preferred embodiment, the neutron emitting material may be Californium (Cf<225>).
Patent IL-149113-A0 (IL)
Title: Fluid absorbing, adhesive hydrocolloid compositions
IPC: A61L15/16
Filed: 2000-10-13
Abstract: A pressure sensitive hot melt adhesive composition suitable for use in a variety of medical products, as well as consumer and industrial products, comprises one or more pressure-sensitive adhesive matrices and at least 0.5 wt. %, based on the total formulation of trans-polyoctenamer. The adhesive composition adheres well to human and other mammalian skin, and can be used for example to secure wound dressings and ostomy appliances.
Patent IL-150311-A0 (IL)
Title: Sulfonamides and derivatives thereof that modulate the activity of endothelin
IPC: A61P1/00
Filed: 2000-12-29
Abstract: Thienyl-, furyl-, pyrrolyl- and phenylsulfonamides, formulations of pharmaceutically-acceptable derivatives thereof and methods for modulating or altering the activity of the endothelin family of peptides are provided. In particular, N-(isoxazolyl)thienylsulfonamides, N-(isoxazolyl)furylsulfonamides, N-(isoxazolyl)pyrrolylsulfonamides and N-(isoxazolyl)phenylsulfonamides, formulations thereof and methods using these sulfonamides for inhibiting the binding of an endothelin peptide to an endothelin receptor by contacting the receptor with the sulfonamide are provided. Methods for treating endothelin-mediated disorders by administering effective amounts of one or more of these sulfonamides or pharmaceutically acceptable derivatives thereof that inhibit the activity of endothelin are also provided.
Patent IL-154851-A0 (IL)
Title: System and method for controlling the multicast traffic of a data packet switch
IPC: H04L12/18
Filed: 2001-09-06
Abstract: A data switch is provided which routes fixed-size data packets from input ports to output ports, using shared memory which holds a copy of each packet in buffers. Output ports have a queue which contains pointers to buffers holding packets bound for that port. The number of shared memory buffers holding packets is compared to the number of buffer pointers in the output queues. In this way, a Multicast Index (MCI), a metric of the level of multicast traffic, is derived. The switch includes a Switch Core Adaptation Layer (SCAL) which has a multicast input queue. Because traffic is handled based on priority class P, a multicast threshold MCT(P), associated with the multicast input queue, is established per priority. While receiving traffic, the MCI is updated and, for each priority class in each SCAL, the MCI is compared to the MCT(P) to determine whether corresponding multicast traffic must be held.
Patent IL-158975-A0 (IL)
Title: 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
IPC: A61P35/02
Filed: 2002-05-24
Abstract: Compounds of the formula (I): wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, p, q, and X are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
Patent IL-182605-A0 (IL)
Title: Fluid control device with manually depressed actuator
Filed: 2007-04-17
Abstract: Fluid control device (70) including a housing (31) with a syringe port (33) for receiving a syringe, a vial adapter port (36) with a vial adapter (86) for snap fit receiving a vial, and a drug administration port (34) for administering a liquid drug. The vial adapter is intended to be rotationally detached after a mixing procedure for discarding together with a spent vial. The fluid control device additionally includes a manually depressed actuator (74) for sealing pathways which may lead to leakage of liquid drug subsequent to vial adapter detachment, thereby facilitating their use for handling and administration of hazardous liquid drugs. The manually depressed actuator preferably precludes vial adapter detachment prior to actuation, thereby ensuring failsafe operation.
Patent IL-184873-A0 (IL)
Title: Method for determining responsiveness to chk1 inhibitors
Filed: 2007-07-26
Abstract: The invention is directed at a method for predicting a patient's responsiveness to a CHK1 inhibitor The method includes providing a sample from a test patient who is being treated with a DNA damaging agent; and determining for the presence of an activated CHK1 signal transduction pathway molecule, wherein the presence of an activated CHK1 signal transduction pathway molecule is indicative that a CHK1 inhibitor should be administered to the patient.